Mersana Therapeutics, Inc. (MRSN) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Stay updated on Mersana Therapeutics, Inc. (MRSN) stock with short-term forecast for year 2025 and long-term price prediction for 2025 - 2050. Access historical performance, see analyst ratings, and follow the latest Mersana Therapeutics, Inc. news and developments.
1 Month Prediction
$4.32 [692.78%]
3 Month Prediction
$3.37 [519.39%]
6 Month Prediction
$4.73 [768.26%]
1 Year Prediction
$5.64 [936.51%]
3 Year Prediction
$4.46 [719.86%]
5 Year Prediction
$3.09 [468.35%]
About Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel antibody-drug conjugates (ADCs) to treat cancer. The company has developed proprietary ADC platforms, including Dolasynthen for cytotoxic payloads and Immunosynthen for immunostimulatory payloads. Its pipeline includes Emi-Le (XMT-1660), targeting B7-H4, and XMT-2056, targeting a novel HER2 epitope.
The company was founded in 2001, and is headquartered in Cambridge, Massachusetts.
Mersana Therapeutics, Inc. (MRSN) Historical Performance
IPO Date
Mersana Therapeutics, Inc. (NASDAQ:MRSN) went public on 28 June, 2017.
Change
Since inception, MRSN has decreased by 96.10%. In the last 5 years, MRSN has fallen from $9.03 to $0.54, a massive -93.97% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $26.61 and a low of $0.52.
52 Week Range
$0.463
$6.28
The current price $0.54 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
MRSN Stock Price History
Based on MRSN stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the MRSN stock has fallen from $5.83 - $26.61 to $0.52 - $0.61, which is down -84.4%. Currently, the stock follows downward trend.
Here, we have calculated stock range of MRSN, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $5.83 - $26.61 | $17.01 | 373.96 | 1 Year Change |
| 2021 | $6.22 - $19.06 | $12.76 | 255.54 | 2 Year Change |
| 2022 | $3.34 - $7.86 | $5.36 | 49.35 | 3 Year Change |
| 2023 | $1.11 - $7.52 | $3.39 | -5.54 | 4 Year Change |
| 2024 | $1.43 - $5.44 | $2.63 | -26.72 | 5 Year Change |
| 2025 | $0.52 - $0.61 | $0.56 | -84.4 | 6 Year Change |
MRSN Price Performance
6-Month Performance
MRSN stock dropped by 69.93% in the last six months.
1-Year Performance
The stock has trended downwards by 82.83% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 84.36%.
5-Year Performance
In the last 5 years, the stock has gone down by 93.97%.
According to Mersana Therapeutics, Inc.'s historical data, below graph gives us the exact picture of how the MRSN stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
364.40% ↑
2021
76.63% ↓
2022
5.79% ↓
2023
60.41% ↓
2024
38.36% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Mersana Therapeutics, Inc. (MRSN) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $16.36 M (Q4)
Revenue for Q4 ending 31st December, 2024 increased 29.87% compared to Q3 ending 30th September, 2024.
Annual Revenue: $40.50 M (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
If compared to the last 4 years, the revenue has gone up from $43.00 thousand to $40.50 million, a 94,079.07% change.
Market Capitalization
Mersana Therapeutics, Inc. has a market capitalization of $67.84M, which places MRSN in the micro-cap category.
Fundamental Analysis
EPS: $-0.11 (Q4), $-0.56 (1Y)
EPS increased 22.22% since last quarter, and decreased 62.16% since last year.
Net Income: $-14.12 M (Q4), $-69.19 M (1Y)
Net Income increased 22.75% since last quarter, and decreased 59.69% since last year.
Free Cash Flow: $-19.25 M (Q4), $-82.47 M (1Y)
Free Cash Flow increased 124.45% since last quarter, and decreased 51.78% since last year.
Net Profit Margin: -86.28% (Q4), -170.86% (1Y)
Net Profit Margin decreased 5.49% since last quarter, and decreased 59.69% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for MRSN stock. These indicators help you understand Mersana Therapeutics, Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for MRSN stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $0.57 |
| SMA50 | $0.78 |
| SMA200 | $1.69 |
| RSI | 43.87 |
| Beta | 1.65 |
SMA20 > Current Price
This signals MRSN stock is in short-term bearish momentum.
SMA50 > Current Price
This signals MRSN stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals MRSN stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for MRSN stock is Bearish. Out of all indicators, 2 indicates bullish signals, 4 signals bearish trends and 3 gives neutral trends. The MRSN stock forecast was last updated on 08 March, 2025.
Mersana Therapeutics, Inc. (MRSN) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $4.10 by the end of 2025, and can reach around $4.59 to $2.43 in 2026. And, the long-term forecast suggests that the stock may further jump to $2.10 - $2.42 in 2028, and $1.00 - $0.91 by 2031. So, the MRSN stock shows a strong upward trend in the next several years.
Short-term MRSN Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $4.32 | 693.68% |
| 2025-05 | $3.46 | 535.68% |
| 2025-06 | $3.37 | 519.14% |
| 2025-07 | $3.79 | 596.31% |
| 2025-08 | $3.93 | 622.03% |
| 2025-09 | $4.73 | 769.01% |
| 2025-10 | $2.81 | 416.26% |
| 2025-11 | $3.39 | 522.82% |
| 2025-12 | $4.10 | 653.26% |
In 2025, the MRSN stock price is expected to fluctuate between $2.81 and $4.73. According to the monthly forecast, the stock could rise to $4.10 by December 2024. If compared to the MRSN's current price, the stock could gain 653.26% by the end of this year.
Long-term MRSN Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $4.59 | $4.19 | $2.43 | 346.44% |
| 2027 | $1.53 | $0.42 | $1.71 | 214.16% |
| 2028 | $2.10 | $5.17 | $2.42 | 344.61% |
| 2029 | $2.44 | $3.17 | $1.09 | 100.26% |
| 2030 | $0.86 | $3.00 | $1.12 | 105.77% |
| 2031 | $1.00 | $1.34 | $0.91 | 67.19% |
| 2032 | $0.73 | $1.52 | $1.02 | 87.4% |
| 2033 | $1.49 | $1.21 | $0.59 | 8.4% |
| 2034 | $1.12 | $0.87 | $1.27 | 133.33% |
| 2035 | $0.66 | $1.31 | $0.30 | -44.88% |
| 2036 | $1.28 | $1.18 | $1.03 | 89.23% |
| 2037 | $1.13 | $1.05 | $1.89 | 247.23% |
| 2038 | $1.47 | $1.23 | $1.37 | 151.7% |
| 2039 | $1.24 | $0.84 | $1.26 | 131.49% |
| 2040 | $0.66 | $1.13 | $1.97 | 261.93% |
| 2041 | $1.07 | $0.67 | $1.18 | 116.79% |
| 2042 | $0.73 | $0.50 | $1.06 | 94.75% |
| 2043 | $1.09 | $0.86 | $1.34 | 146.19% |
| 2044 | $0.60 | $1.02 | $1.12 | 105.77% |
| 2045 | $1.47 | $0.71 | $1.05 | 92.91% |
| 2046 | $1.23 | $1.56 | $0.92 | 69.02% |
| 2047 | $1.33 | $0.51 | $0.77 | 41.47% |
| 2048 | $1.33 | $0.91 | $0.93 | 70.86% |
| 2049 | $0.63 | $1.67 | $1.34 | 146.19% |
| 2050 | $0.73 | $0.58 | $0.68 | 24.93% |
| 2051 | $1.35 | $1.50 | $0.75 | 37.79% |
Mersana Therapeutics, Inc. (MRSN) Stock Price Prediction & Forecast 2025
At the start of 2025, the MRSN stock was at $0.61. Today, it is trading at $0.54, which is -10.62% decrease from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $4.10 by December 2025 with a 653.26% change.
Mersana Therapeutics, Inc. (MRSN) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant depreciation in the MRSN stock. During this period, the MRSN's price is forecasted to shift from $4.59 to $1.12, which is -75.60% loss.
In 2026, the stock would possibly open at $4.59, descends to $4.19 by mid-year, and wraps up at $2.43, reflecting a 345.93% increase from today's price. Further moving to 2030, the stock can kick off the year at $0.86, drop to $3.00 by mid-year, and finish at $1.12, which is 106.02% change from current price.
Mersana Therapeutics, Inc. (MRSN) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $1.00 to $1.97, which is up 67.38%
In 2031, we can expect MRSN to fluctuate between $0.91 and $1.00, a shift indicating a 67.38% gain by year-end compared to current price. And Until 2040, MRSN can likely vary from $0.66 to $1.97. By the end of 2040, the stock could record a 261.57% rise from today's stock price.
Mersana Therapeutics, Inc. (MRSN) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the MRSN stock can see an a downturn from $1.07 to $0.68 in this period. In 2041, the stock can experience a low of $0.67 by mid-year, closing the year at $1.18. This results in a 23.07% increase from today.
Moving towards the end of 2050, MRSN is projected to open the year at $0.73. The stock may dip to $0.58 during mid-year and finish the year at $0.68. Compared to the stock's current price, this translates to an overall gain of 25.41% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
MRSN Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| TNYA | Tenaya Therapeutics, Inc. | - | $0.46 | -54.95% ▼ | $790.53 ▲ |
| XERS | Xeris Biopharma Holdings, Inc. | - | $4.13 | 7.83% ▲ | $41.7 ▲ |
| PSTV | Plus Therapeutics, Inc. | - | $1.44 | 97.26% ▲ | $70.11 ▲ |
| NTLA | Intellia Therapeutics, Inc. | - | $9.10 | -9.86% ▼ | $208.86 ▲ |
| ONVO | Organovo Holdings, Inc. | - | $1.27 | 252.78% ▲ | -3.29 ▼ |
Last updated Mar 08 at 1:36 PM
MRSN : Buy, Sell Or Hold?
Analyst Ratings
Based on 10 analysts, 0 rated as a strong buy, 8 recommended a buy, 2 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 8 analysts, 0 analysts gave a strong buy rating, 7 a buy rating, 1 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for MRSN stock is Buy.
Expert Analysis
According to MRSN short-term and long-term forecast, Mersana Therapeutics, Inc. shares are projected to go up by 24.93%, and reach a value of $0.68 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, MRSN has recorded 7/30 green days, which reflects a 31.818181818181817% positivity rate with a price volatility of 0.08%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that MRSN stock is undervalued. So, Based on MRSN prediction and analysis, it may be the best time to sell MRSN stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "MRSN” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.